The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Acquisition for Equifax Inc.
Represented Equifax Inc., one of the United States' largest credit reporting agencies, as buyer's counsel in an acquisition. more
Executive compensation and employee benefits matters for a Massachusetts bank holding company
Represents a Massachusetts bank holding company on executive compensation and employee benefits matters, including matters related to employee stock more
Patent prosecution and licensing matters for Emageon Inc.
Represented Emageon Inc., a publicly traded provider of healthcare-related, dynamic user interface technologies and software for managing medical more
Litigation for pharmaceutical manufacturer
Represented pharmaceutical manufacturer as national co-counsel in more than 50 individual lawsuits and product liability class actions across more